ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation

NCT01972035 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

137

Enrollment

OTHER

Sponsor class

Conditions

Transplantation Infection
Epstein-Barr Virus Infections
Cytomegalovirus Infections

Interventions

DRUG: Valacyclovir
DRUG: Valganciclovir

Sponsor

University of Minnesota